1 row is stored for this page
| Field | Field type | Value |
|---|
| generic | String | Tadalafil |
| brand | String | Cialis, Adcirca |
| structure | File | |
| classes | List of String, delimiter: , | PDE5 Inhibitor |
| mechanism | String | Selective inhibitor of PDE5 with a substantially longer half-life than other PDE5 inhibitors, allowing once-daily continuous dosing. |
| uses | String | '"`UNIQ--vote-00000738-QINU`"', '"`UNIQ--vote-00000739-QINU`"', '"`UNIQ--vote-0000073A-QINU`"' |
| starting_dose | String | 10 mg PRN; 2.5–5 mg daily for continuous coverage / BPH |
| preparations | String | 2.5, 5, 10, 20 mg tabs |
| fda_max | String | 20 mg/d (ED, PRN); 5 mg/d (daily / BPH); 40 mg/d (PAH) |
| pill_id | Text | |
| routes | List of String, delimiter: , | Oral |
| onset | String | 30 min |
| duration | String | Up to 36 h ("the weekend pill") |
| halflife | String | ~17.5 h |
| bioavailability | String | Reasonable (not formally established as a percentage) |
| pregnancy | String | Category B |
| legal | String | Rx-only in US |
